Photo of Myriam Chalabi taken from avl.nl
May 1, 2025, 00:23
Myriam Chalabi presented the first results from the NEOASIS study at AACR25 – Agenus
Agenus shared a post on LinkedIn:
“Today at AACR25, Dr. Myriam Chalabi presented the first results from the NEOASIS study, evaluating neoadjuvant botensilimab/balstilimab in early-stage MSS and MSI-H cancers, including colorectal and breast cancers.
More posts from AACR25.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jul 27, 2025, 14:04
Jul 27, 2025, 13:56
Jul 27, 2025, 13:48
Jul 27, 2025, 13:42
Jul 27, 2025, 13:03
Jul 27, 2025, 07:35